Horizon Discovery

company

About

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
£11.30M
Industries
Biopharma,Biotechnology,Genetics,Health Diagnostics
Founded date
Jun 1, 2007
Number Of Employee
251 - 500
Operating Status
Active

Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£18.20M
Horizon Discovery has raised a total of £18.20M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2013 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 3, 2013 Series Unknown £6.90M 1 Detail
Sep 13, 2011 Series C £11.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Horizon Discovery is funded by 1 investors. Molten Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Molten Ventures Series Unknown